Document Detail


Assessing efficacy/effectiveness and safety/tolerability profiles of adjunctive pramipexole in bipolar depression: acute versus long-term data.
MedLine Citation:
PMID:  24081199     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Bipolar depression represents the most difficult-to-treat phase of bipolar disorder, mood-stabilizing compounds and second-generation antipsychotics being only partially effective, whereas the use of antidepressants is highly controversial because of risks of inefficacy, switching, rapid cycling, and increased suicidality. Among various augmentative pharmacological treatments, compounds with dopamine-enhancing activity have been shown to be variably beneficial in the treatment of bipolar depression with drug-resistance features. In particular, pramipexole - a dopamine D2/D3 receptor agonist - showed antidepressant properties in bipolar depressed patients in both randomized-controlled trials and open acute and follow-up reports. The present review aims to provide an updated perspective on the use of adjunctive pramipexole in bipolar depression, taking into account randomized-controlled trials, as well as open naturalistic studies, with a specific focus on the evaluation of acute versus long-term data in terms of effectiveness and tolerability. Despite methodological differences, short-term studies support the acute efficacy and tolerability/safety of adjunctive pramipexole, whereas open extended observations seem to confirm the effectiveness of the compound, with some additional concern in terms of safety and tolerability issues. Adjunctive pramipexole may be a valid option in both the acute and the long-term treatment of drug-resistant bipolar depression, with possible superior tolerability in the short term.
Authors:
Bernardo Dell'osso; Terence A Ketter
Related Documents :
25110879 - Cancer family caregiver depression: are religion-related variables important?
17447389 - Antiretroviral treatment adherence and its correlates in addis ababa, ethiopia.
24316199 - The influence of anhedonia on feedback negativity in major depressive disorder.
12957559 - On reducing hand impact force in forward falls: results of a brief intervention in youn...
24160459 - Depression among patients with end-stage renal disease in hemodialysis.
11394559 - A computerized social cognitive intervention for nutrition behavior: direct and mediate...
17721699 - Measuring health-related quality of life in drug clinical trials: is it given due impor...
15784799 - The antitussive effect of placebo treatment on cough associated with acute upper respir...
8270929 - Dorsolateral prefrontal cortex dysfunction in the major psychoses; symptom or disease s...
Publication Detail:
Type:  JOURNAL ARTICLE    
Journal Detail:
Title:  International clinical psychopharmacology     Volume:  28     ISSN:  1473-5857     ISO Abbreviation:  Int Clin Psychopharmacol     Publication Date:  2013 Nov 
Date Detail:
Created Date:  2013-10-1     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8609061     Medline TA:  Int Clin Psychopharmacol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  297-304     Citation Subset:  -    
Affiliation:
aDepartment of Psychiatry, University of Milan, Fondazione IRCCS Ca'Granda, Ospedale Maggiore Policlinico, Milan, Italy bDepartment of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Electronic Approaches to Restitute Vision in Patients with Neurodegenerative Diseases of the Retina.
Next Document:  An Evaluation of Nest-Building Behavior by Sanctuary Chimpanzees with Access to Forested Habitats.